CN101314601B - 一种高纯度盐酸帕洛诺司琼的制备工艺 - Google Patents
一种高纯度盐酸帕洛诺司琼的制备工艺 Download PDFInfo
- Publication number
- CN101314601B CN101314601B CN 200810122766 CN200810122766A CN101314601B CN 101314601 B CN101314601 B CN 101314601B CN 200810122766 CN200810122766 CN 200810122766 CN 200810122766 A CN200810122766 A CN 200810122766A CN 101314601 B CN101314601 B CN 101314601B
- Authority
- CN
- China
- Prior art keywords
- preparation technology
- crude product
- ethanol
- purity
- water
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 27
- OLDRWYVIKMSFFB-SSPJITILSA-N palonosetron hydrochloride Chemical compound Cl.C1N(CC2)CCC2[C@@H]1N1C(=O)C(C=CC=C2CCC3)=C2[C@H]3C1 OLDRWYVIKMSFFB-SSPJITILSA-N 0.000 title abstract description 57
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000012535 impurity Substances 0.000 claims abstract description 15
- 238000010898 silica gel chromatography Methods 0.000 claims abstract description 6
- 229960002131 palonosetron Drugs 0.000 claims description 54
- 239000012043 crude product Substances 0.000 claims description 29
- 229960004756 ethanol Drugs 0.000 claims description 13
- 238000001953 recrystallisation Methods 0.000 claims description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 8
- 238000004090 dissolution Methods 0.000 claims description 8
- CPZBLNMUGSZIPR-NVXWUHKLSA-N palonosetron Chemical compound C1N(CC2)CCC2[C@@H]1N1C(=O)C(C=CC=C2CCC3)=C2[C@H]3C1 CPZBLNMUGSZIPR-NVXWUHKLSA-N 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 229960000935 dehydrated alcohol Drugs 0.000 claims description 6
- 239000012141 concentrate Substances 0.000 claims description 5
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 4
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 3
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 2
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 claims description 2
- 238000001914 filtration Methods 0.000 abstract description 13
- 238000001035 drying Methods 0.000 abstract description 5
- 229960003359 palonosetron hydrochloride Drugs 0.000 abstract description 5
- CPZBLNMUGSZIPR-RDJZCZTQSA-N (3ar)-2-[(3r)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3h-benzo[de]isoquinolin-1-one Chemical compound C1N(CC2)CCC2[C@H]1N1C(=O)C(C=CC=C2CCC3)=C2[C@@H]3C1 CPZBLNMUGSZIPR-RDJZCZTQSA-N 0.000 abstract 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 abstract 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 26
- 239000000047 product Substances 0.000 description 15
- 238000000034 method Methods 0.000 description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 239000007787 solid Substances 0.000 description 10
- 238000010438 heat treatment Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 239000002994 raw material Substances 0.000 description 7
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- 238000004821 distillation Methods 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- 239000012452 mother liquor Substances 0.000 description 4
- 239000003369 serotonin 5-HT3 receptor antagonist Substances 0.000 description 4
- LNETULKMXZVUST-UHFFFAOYSA-N 1-naphthoic acid Chemical compound C1=CC=C2C(C(=O)O)=CC=CC2=C1 LNETULKMXZVUST-UHFFFAOYSA-N 0.000 description 3
- 229940113081 5 Hydroxytryptamine 3 receptor antagonist Drugs 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 239000002244 precipitate Substances 0.000 description 3
- 239000013557 residual solvent Substances 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- NNBZCPXTIHJBJL-UHFFFAOYSA-N decalin Chemical compound C1CCCC2CCCCC21 NNBZCPXTIHJBJL-UHFFFAOYSA-N 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 229960001866 silicon dioxide Drugs 0.000 description 2
- FELGMEQIXOGIFQ-CYBMUJFWSA-N (3r)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1h-carbazol-4-one Chemical compound CC1=NC=CN1C[C@@H]1C(=O)C(C=2C(=CC=CC=2)N2C)=C2CC1 FELGMEQIXOGIFQ-CYBMUJFWSA-N 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 229940014175 aloxi Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- UKTAZPQNNNJVKR-KJGYPYNMSA-N chembl2368925 Chemical compound C1=CC=C2C(C(O[C@@H]3C[C@@H]4C[C@H]5C[C@@H](N4CC5=O)C3)=O)=CNC2=C1 UKTAZPQNNNJVKR-KJGYPYNMSA-N 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229960003413 dolasetron Drugs 0.000 description 1
- 229960003727 granisetron Drugs 0.000 description 1
- MFWNKCLOYSRHCJ-BTTYYORXSA-N granisetron Chemical compound C1=CC=C2C(C(=O)N[C@H]3C[C@H]4CCC[C@@H](C3)N4C)=NN(C)C2=C1 MFWNKCLOYSRHCJ-BTTYYORXSA-N 0.000 description 1
- 238000007327 hydrogenolysis reaction Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- BYVCTYDTPSKPRM-UHFFFAOYSA-N naphthalene-1-carbonyl naphthalene-1-carboxylate Chemical compound C1=CC=C2C(C(OC(=O)C=3C4=CC=CC=C4C=CC=3)=O)=CC=CC2=C1 BYVCTYDTPSKPRM-UHFFFAOYSA-N 0.000 description 1
- 229960005343 ondansetron Drugs 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 229910000033 sodium borohydride Inorganic materials 0.000 description 1
- 239000012279 sodium borohydride Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
Images
Abstract
Description
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810122766 CN101314601B (zh) | 2008-06-30 | 2008-06-30 | 一种高纯度盐酸帕洛诺司琼的制备工艺 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN 200810122766 CN101314601B (zh) | 2008-06-30 | 2008-06-30 | 一种高纯度盐酸帕洛诺司琼的制备工艺 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101314601A CN101314601A (zh) | 2008-12-03 |
CN101314601B true CN101314601B (zh) | 2011-01-12 |
Family
ID=40105754
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN 200810122766 Active CN101314601B (zh) | 2008-06-30 | 2008-06-30 | 一种高纯度盐酸帕洛诺司琼的制备工艺 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101314601B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011001400A2 (en) | 2009-06-30 | 2011-01-06 | Ranbaxy Laboratories Limited | Processes for the preparation of form i and form ii of palonosetron hydrochloride |
CN104003985B (zh) * | 2014-06-24 | 2016-07-06 | 浙江仙琚制药股份有限公司 | 一种盐酸帕洛诺司琼及其中间体的制备方法 |
-
2008
- 2008-06-30 CN CN 200810122766 patent/CN101314601B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN101314601A (zh) | 2008-12-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107353201A (zh) | 一种高含量天然莽草酸提取物及其制备方法 | |
US20080262223A1 (en) | Isolation of Galanthamine From Biological Material | |
CN102887877A (zh) | 一种纯化卡巴他赛的方法 | |
CN101314601B (zh) | 一种高纯度盐酸帕洛诺司琼的制备工艺 | |
CN1733753A (zh) | 一种表没食子儿茶素没食子酸酯单体的纯化方法 | |
CN101624351A (zh) | 一种dl-赖氨酸的制备方法 | |
CN104844620A (zh) | 一种雷帕霉素的分离纯化方法 | |
CN110734467A (zh) | 一种从发酵液中提取纯化多杀霉素的方法 | |
CN111714953B (zh) | 一种脱除提取物中邻苯二甲酸酯类塑化剂的方法 | |
CN102432530A (zh) | 一种高纯度的吉美嘧啶的制备方法 | |
CN102603603B (zh) | 一种制备(s)-奥拉西坦的方法 | |
CN107033114B (zh) | 一种二氢杨梅素的分离纯化方法 | |
CN111171096B (zh) | 一种多杀菌素的提取方法 | |
CN102603597B (zh) | (s)-奥拉西坦的制备方法 | |
CN106831919A (zh) | 生物转化17α-羟基黄体酮生产11α,17α-双羟基黄体酮的提取工艺 | |
CN102351869B (zh) | 一种溴化甲基纳曲酮的制备方法 | |
CN101607893B (zh) | 从食用级枸橼酸获得药用级枸橼酸的方法 | |
CN102603595B (zh) | (s)-奥拉西坦的制备方法 | |
CN101353294A (zh) | 高含量白藜芦醇分离纯化的方法 | |
CN103554133A (zh) | 一种制备高纯度他克莫司的工艺 | |
CN105085524A (zh) | 一种制备高纯度盐酸缬更昔洛韦的方法 | |
CN103193800A (zh) | 一种从头孢克洛酶促反应液中分离纯化各组分的方法 | |
CN105713004A (zh) | 一种高品质盐酸伊立替康三水合物晶型的制备方法 | |
CN101367821B (zh) | 用于高纯药源单体的河豚毒素的制备方法 | |
CN105061447B (zh) | 一种喜树碱的分离纯化方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20081203 Assignee: Shanghai Simcere Pharmaceutical Co., Ltd. Assignor: Jiangsu Simcere Pharmaceutical Research Company Limited Contract record no.: 2012320000962 Denomination of invention: Preparation process of high-purity palonosetron Hcl Granted publication date: 20110112 License type: Exclusive License Record date: 20120926 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
ASS | Succession or assignment of patent right |
Owner name: JIANGSU SIMCERE PHARMACEUTICAL CO., LTD. Effective date: 20150625 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150625 Address after: 210042 Xuanwu Avenue, Jiangsu, Nanjing, No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu Avenue, Jiangsu, Nanjing, No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20150914 Address after: 211800, No. 8, prosperous road, Pukou Economic Development Zone, Jiangsu, Nanjing Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee after: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 210042 Xuanwu Avenue, Jiangsu, Nanjing, No. 699 -18 Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160729 Address after: 210042 Xuanwu District, Xuanwu District, Jiangsu, Nanjing No. 699 -18 Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 211800 Pukou, Jiangsu Province Economic Development Zone, Nanjing Road, No. prosperous road, No. 8 Patentee before: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20160811 Address after: 211800 Pukou, Jiangsu Province Economic Development Zone, Nanjing Road, No. prosperous road, No. 8 Patentee after: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee after: Jiangsu Simcere Pharmaceutical Co., Ltd. Address before: 211800 Pukou, Jiangsu Province Economic Development Zone, Nanjing Road, No. prosperous road, No. 8 Patentee before: Nanjing Simcere Dongyuan Pharmaceutical Co., Ltd. Patentee before: Jiangsu Simcere Pharmaceutical Research Company Limited Patentee before: Jiangsu Simcere Pharmaceutical Co., Ltd. |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: No.99, Huakang Road, Jiangbei new district, Nanjing, Jiangsu Province, 210032 Patentee after: SIMCERE PHARMACEUTICAL Group Patentee after: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. Address before: 211800, No. 8, prosperous road, Pukou Economic Development Zone, Nanjing, Jiangsu, Nanjing Patentee before: NANJING SIMCERE DONGYUAN PHARMACEUTICA Co.,Ltd. Patentee before: JIANGSU SIMCERE PHARMACEUTICAL Co.,Ltd. |